1. Home
  2. NTIC vs ATYR Comparison

NTIC vs ATYR Comparison

Compare NTIC & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northern Technologies International Corporation

NTIC

Northern Technologies International Corporation

HOLD

Current Price

$7.57

Market Cap

77.9M

Sector

Industrials

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.74

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTIC
ATYR
Founded
1970
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
77.9M
79.2M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
NTIC
ATYR
Price
$7.57
$0.74
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$8.75
AVG Volume (30 Days)
34.7K
2.0M
Earning Date
01-09-2026
11-06-2025
Dividend Yield
0.53%
N/A
EPS Growth
N/A
N/A
EPS
0.00
N/A
Revenue
$84,234,474.00
$190,000.00
Revenue This Year
$7.89
N/A
Revenue Next Year
N/A
$18,728.88
P/E Ratio
$4,073.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.75
$0.64
52 Week High
$14.20
$7.29

Technical Indicators

Market Signals
Indicator
NTIC
ATYR
Relative Strength Index (RSI) 48.49 42.35
Support Level $7.50 $0.69
Resistance Level $7.98 $0.76
Average True Range (ATR) 0.19 0.04
MACD 0.02 0.01
Stochastic Oscillator 36.51 29.49

Price Performance

Historical Comparison
NTIC
ATYR

About NTIC Northern Technologies International Corporation

Northern Technologies International Corp, or NTIC is a United States-based firm that develops and markets environmentally beneficial products and services world-wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: